COVID-19 Convalescent Plasma Shows Early Survival Benefit
Researchers assessed the efficacy of the COVID-19 convalescent plasma in offering survival benefit at 7 and 14 days for patients hospitalized with the disease.
Researchers assessed the efficacy of the COVID-19 convalescent plasma in offering survival benefit at 7 and 14 days for patients hospitalized with the disease.